Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RODICA BUSUI

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1235211764
CMS profile
11050
Location
PORTLAND, OR

General Payments · PY2018–2024

$176,212.24

  • Reported across 141 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$52,981.64

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Mylan Inc. $18,351.20 3
ROCHE DIAGNOSTICS INTERNATIONAL LTD $14,458.65 6
Lexicon Pharmaceuticals, Inc. $11,354.02 4
Corcept Therapeutics $3,386.51 2
Roche Diagnostics Corporation $2,285.00 2
Bayer HealthCare Pharmaceuticals Inc. $1,657.10 11
Nevro Corp. $1,352.54 3
Averitas Pharma Inc. $136.62 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $8,995.29 17
PY2019 $25,720.93 32
PY2020 $20,149.58 10
PY2021 $23,477.05 18
PY2022 $23,243.15 20
PY2023 $21,644.60 12
PY2024 $52,981.64 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Averitas Pharma Inc. $136.62 01/19/2024 Food and Beverage Undisputed 01/23/2026 1133420041 CMS
Bayer Healthcare Pharmaceuticals Inc. $186.10 03/13/2024 Travel and Lodging Undisputed 01/23/2026 1086080982 CMS
Bayer Healthcare Pharmaceuticals Inc. $206.50 03/13/2024 Travel and Lodging Undisputed 01/23/2026 1086080984 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.55 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086122116 CMS
Bayer Healthcare Pharmaceuticals Inc. $105.02 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086174138 CMS
Bayer Healthcare Pharmaceuticals Inc. $206.20 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1086080600 CMS
Bayer Healthcare Pharmaceuticals Inc. $685.19 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1086080638 CMS
Bayer Healthcare Pharmaceuticals Inc. $95.48 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086141023 CMS
Bayer Healthcare Pharmaceuticals Inc. $32.00 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086155260 CMS
Bayer Healthcare Pharmaceuticals Inc. $33.03 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086155262 CMS
Bayer Healthcare Pharmaceuticals Inc. $50.00 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086235628 CMS
Bayer Healthcare Pharmaceuticals Inc. $33.03 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086258270 CMS
Corcept Therapeutics $124.01 06/21/2024 Food and Beverage Undisputed 01/23/2026 1117781347 CMS
Corcept Therapeutics $3,262.50 07/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117781345 CMS
Lexicon Pharmaceuticals, Inc. $4,815.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1081726933 CMS
Lexicon Pharmaceuticals, Inc. $761.20 02/28/2024 Travel and Lodging Undisputed 01/23/2026 1081726931 CMS
Lexicon Pharmaceuticals, Inc. $5,350.00 02/28/2024 Consulting Fee Undisputed 01/23/2026 1081726935 CMS
Lexicon Pharmaceuticals, Inc. $427.82 04/29/2024 Food and Beverage Undisputed 01/23/2026 1081726929 CMS
Mylan Inc. $9,198.20 10/07/2024 Travel and Lodging Undisputed 01/23/2026 1147272206 CMS
Mylan Inc. $115.00 12/13/2024 Travel and Lodging Undisputed 01/23/2026 1147272178 CMS
Mylan Inc. $9,038.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1147272180 CMS
Nevro Corp. $70.66 06/22/2024 Food and Beverage Undisputed 01/23/2026 1130785946 CMS
Nevro Corp. $81.88 06/22/2024 Food and Beverage Undisputed 01/23/2026 1130786052 CMS
Nevro Corp. $1,200.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1130786056 CMS
Roche Diagnostics Corporation $1,142.05 12/17/2024 Consulting Fee Undisputed 01/23/2026 1089610836 CMS
Roche Diagnostics Corporation $1,142.95 12/17/2024 Consulting Fee Undisputed 01/23/2026 1089610838 CMS
ROCHE DIAGNOSTICS INTERNATIONAL LTD $10,383.96 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1137031413 CMS
ROCHE DIAGNOSTICS INTERNATIONAL LTD $404.19 10/02/2024 Food and Beverage Undisputed 01/23/2026 1137031254 CMS
ROCHE DIAGNOSTICS INTERNATIONAL LTD $976.18 10/02/2024 Travel and Lodging Undisputed 01/23/2026 1137031616 CMS
ROCHE DIAGNOSTICS INTERNATIONAL LTD $41.35 11/04/2024 Food and Beverage Undisputed 01/23/2026 1137031542 CMS
ROCHE DIAGNOSTICS INTERNATIONAL LTD $197.97 11/11/2024 Travel and Lodging Undisputed 01/23/2026 1137031522 CMS
ROCHE DIAGNOSTICS INTERNATIONAL LTD $2,455.00 11/11/2024 Consulting Fee Undisputed 01/23/2026 1137031628 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.